期刊文献+

microRNA在卵清蛋白诱导的支气管哮喘小鼠模型中的表达 被引量:5

Expressions of microRNA in Murine Asthma Model Induced by Ovalbumin
原文传递
导出
摘要 目的研究与肥大细胞功能相关的microRNA在卵清蛋白(OVA)诱导的支气管哮喘小鼠模型中的表达差异。方法采用OVA诱导的支气管哮喘小鼠模型,通过检测肺泡灌洗液(BALF)中细胞数及组织病理验证模型的成功建立。应用实时荧光-PCR法检测支气管哮喘小鼠模型肺组织microRNA-223、microRNA-221、microRNA-15、microRNA-374、microRNA-27与正常对照组的表达差异。结果 OVA诱导的支气管哮喘小鼠模型组BALF中细胞总数(12.8±2.2)较正常对照组(5.6±2.5)显著升高(P<0.05);嗜酸性粒细胞数(6.6±1.9)较正常对照组(0.8±0.8)显著升高(P<0.05)。组织病理显示支气管哮喘模型组大鼠炎症细胞浸润明显高于正常对照组。在支气管哮喘组大鼠,microRNA-223的表达约为正常对照组大鼠的3倍(P<0.05);microRNA-532的表达约为正常对照组大鼠的0.5(P<0.05);microRNA-15的表达约为正常对照大鼠的0.4(P<0.05);microRNA-221的表达约为正常对照大鼠的2.5(P<0.05);microRNA-27的表达约为正常对照大鼠的0.2(P<0.05)。结论 5条与肥大细胞功能相关的microRNA在OVA诱导的支气管哮喘小鼠模型中存在差异表达,差异表达的microRNA可能通过调节肥大细胞的功能,参与支气管哮喘的发病。 Objective To investigate the different expressions of microRNA in murine asthma model induced by ovalbumin(OVA). Methods OVA-induced murine asthma model was used in this study.The cell number in bronchoalveolar lavage fluid(BALF) of murine asthma model and lung histological study was assed.Expression of microRNA(microRNA-223,microRNA-221,microRNA-15,microRNA-374,microRNA-27)in ova-induced asthma in a mouse model was analyzed by real time-PCR. Results The cell number was significantly higher in BALF of murine asthma model group(12.8±2.2) than that of normal control group(5.6±2.5)(P〈0.05).Enhanced eosinophilic inflammation in lung was observed in murine asthma model group(6.6±1.9) compared with the normal controls(0.8±0.8)(P〈0.05). The infiltration of leukocytes to lung tissue was upregulated in OVA-induced murine asthma model compared to the controls. Compared to the controls,microRNA-223(about 3 fold,P〈0.05),microRNA-221(about 2.5 fold,P〈0.05) were upregultaed.MicroRNA-532(about 0.5 fold,P〈0.05),microRNA-15(about 0.4 fold,P〈0.05),microRNA-27(about 0.2 fold,P〈0.05) were downregulated. Conclusion These mast cell function related microRNA have differential expressions in murine asthma model induced by OVA,and the microRNA may take part in murine asthma through regulating the function of mast cell.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2012年第21期1655-1657,共3页 Journal of Applied Clinical Pediatrics
基金 南京市医学科技发展资金资助项目(QYK09163)
关键词 哮喘 MICRORNA 肥大细胞 asthma microRNA mast cell
  • 相关文献

参考文献15

  • 1全国儿科哮喘协作组.2000年与1990年儿童支气管哮喘患病率的调查比较[J].中华结核和呼吸杂志,2004,27(2):112-116. 被引量:249
  • 2Masoli M,Fabian D,Holt S,et al. The global burden of asthma:Execu-tive summary of the GINA Dissemination Committee report [ J]. Allergy,2004,59(5).:469 -478.
  • 3van Rooij E,Purcell AL,Levin AA. Developing microRNA therapeutics[J]. Circ i.e5,2012,110(3). :496 -507.
  • 4Chiba Y,Misawa M. MicroRNAs and their therapeutic potential for hu-man diseases: MiR - 133a and bronchial smooth muscle hyperrespon-siveness in asthma[ J]. J Pharmacol ,2010,114(3). :264 -268.
  • 5Liston A,Linterman M,Lu LF. MicroRNA in the adaptive immune sys-tem ,in sickness and in health[ J]. J Clin Immunol,2010,30(3). :339 -346.
  • 6Wang Z, Li Y, Kong D,et al. Cross - talk between miRNA and Notchsignaling pathways in tumor development and progression [ J]. CancerLett,2010 f292(2). :141 -148.
  • 7Gracias DT,Katsikis PD. MicroRNAs:Key components of immune regu-lation [J]. Adv Exp Med Biol y20l 1,780 : 15 -26.
  • 8Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up - regulatesmicroRNA -26 a and induces human airway smooth muscle hypertrophyby suppressing glycogen synthase kinase - 3p [ J]. J Biol Chem,20J0,285(38).:29336 -29347.
  • 9Mattes J, Collison A,Plank M, et al. Antagonism of microRNA - 126suppresses the effector function of TH2 cells and the development of al-lergic airways disease [ J]. Proc Natl Acad Sci U S A ,2009 ,106 (44).;18704 -18709.
  • 10Polikepahad S,Knight JM,Naghavi A0,et al. Proinflammatory role forlet -7 microRNAS in experimental asthma[ J]. l Biol Chemf20J0 t2S5(39). :30139 -30149.

二级参考文献16

共引文献254

同被引文献65

  • 1刘光辉,王忠喜,黄爱霞,祝戎飞,李文静,张威,陈欢.变应原疫苗对变态反应性鼻炎、支气管哮喘患者血清中TIgE及IgG水平的影响[J].药物流行病学杂志,2004,13(4):175-177. 被引量:3
  • 2李宏杰,康淑兰,李俐.支气管哮喘的药物治疗进展[J].药物流行病学杂志,2005,14(5):272-275. 被引量:15
  • 3Boulet LP, Fitzgerald JM,Levy ML,et al. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care[J]. Eur Respir J,2012,39 (5) : 1220-1229.
  • 4Holt PG,Strickland DH. Interactions between innate and adaptive immunity in asthma pathogenesis:new perspec- tives from studies on acute exacerbations[J]. J Allergy Clin Immunol, 2010, 125 (5) : 963-974.
  • 5Kumar RK,Yang M,Herbert C,et al. Interferon-gamma, pulmonary macrophages and airway responsiveness in asthma [J]. Inflamm Allergy Drug Targets,2012,11 (4): 292-297.
  • 6Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effeetor T cells develop via a lineage distinct from the T helper type 1 and 2 lineages [J]. Nat Immunol, 2005,6 ( 11 ) : 1123-1132.
  • 7Onishi RM,Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease[J]. Im- munology, 2010,129 (3) : 311-321.
  • 8Zhao Y,Yang J,Gao YD,et al. Thl7 immunity in patients with allergic asthma[J], lnt Arch Allergy Immunol, 2010, 151(4) :297-307.
  • 9Bradding P. The role of the mast cell in asthma: a re- assessment[J]. Curr Opin Allergy Clin Immunol,2003,3 ( 1 ) :45-50.
  • 10Qin HB,Xu B,Mei JJ,et al. Inhibition of miRNA-221 suppresses the airway inflammation in asthma[J]. Inflam- mation, 2012,35 (4) : 1595-1599.

引证文献5

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部